(Q39705843)

14 September 2017

title

Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia (English)

1 reference

adaptive radiation therapy

14 September 2017

main subject

0 references

author name string

Urban C

1

1 reference

14 September 2017

Benesch M

2

1 reference

14 September 2017

Sykora KW

3

1 reference

14 September 2017

Schwinger W

4

1 reference

14 September 2017

Lackner H

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Bone Marrow Transplantation

14 September 2017

published in

1 reference

14 September 2017

volume

35

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

591-594

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704792

14 September 2017

exact match

0 references

cites work

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Second malignant neoplasms following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Non-endocrine late complications of bone marrow transplantation in childhood: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Non-endocrine late complications of bone marrow transplantation in childhood: part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Endocrine complications of high-dose therapy with stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Use of fludarabine in the treatment of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Non-myeloablative allogeneic transplantation -- state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

A fludarabine-based conditioning regimen for severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704792

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704792

1 reference

14 September 2017

1 reference